PUS1 and renal cell carcinoma: Consistent with their results showing that silencing of PUS1 significantly suppressed breast tumor proliferation and invasion, our data further made a complement for PUS1 function in tumor, providing with evidence that PUS1 would be a potential diagnose marker for cancers, including RCC.